Clinical Trial Results
Showing:
All studies
[change]
Condition: Breast Cancer
Location: Camden, New Jersey
25 trials found
New Search
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RECRUITING
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RECRUITING
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
RECRUITING
CTNNA1 Familial Expansion Study
RECRUITING
Evaluation of Grief Therapy Approaches for Bereaved Parents
RECRUITING
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
RECRUITING
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RECRUITING
Autoimmunity After Checkpoint Blockade
RECRUITING
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
RECRUITING
Prospective Breast Cancer Biospecimen Collection
RECRUITING
ETHAN - ET for Male BC
RECRUITING
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
RECRUITING
eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer
RECRUITING
Role of the Immune Environment in Response to Therapy in Breast Cancer
RECRUITING
Pan Tumor Rollover Study
RECRUITING
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
RECRUITING
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
RECRUITING
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RECRUITING
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RECRUITING
FES BPET-DBT in Newly Diagnosed Breast Cancer
RECRUITING
Galleri® in the Medicare Population.
RECRUITING
[18F] F-GLN by PET/CT in Breast Cancer
RECRUITING
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RECRUITING
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
RECRUITING
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
RECRUITING